These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 681806)

  • 1. Chronic iron overload: new chelators and new strategies.
    Fairbanks VF
    J Lab Clin Med; 1978 Aug; 92(2):141-3. PubMed ID: 681806
    [No Abstract]   [Full Text] [Related]  

  • 2. Iron metabolism and chelation therapy in hemosiderosis.
    Graziano JH
    Curr Top Hematol; 1978; 1():127-50. PubMed ID: 400529
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
    Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
    Trans Assoc Am Physicians; 1977; 90():335-41. PubMed ID: 611665
    [No Abstract]   [Full Text] [Related]  

  • 4. Iron metabolism and iron chelation in the thalassaemia disorders.
    Pippard MJ
    Haematologica; 1990; 75 Suppl 5():66-71. PubMed ID: 2086383
    [No Abstract]   [Full Text] [Related]  

  • 5. [Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].
    Cartei G; Cazzavillan M; Chisesi T; Battista R; Barbui T; Dini E
    Minerva Med; 1978 Mar; 69(13):811-21. PubMed ID: 643223
    [No Abstract]   [Full Text] [Related]  

  • 6. Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias.
    Pippard MJ; Weatherall DJ
    Haematologia (Budap); 1984; 17(1):17-24. PubMed ID: 6724353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload.
    Nienhuis AW; Delea C; Aamodt R; Bartter F; Anderson WF
    Birth Defects Orig Artic Ser; 1976; 12(8):177-85. PubMed ID: 795481
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative evaluation of two models of hemosiderosis for analysis of iron chelators].
    Minina LT; Prostakova TM; Meshchano AIu; Kol'tsova GN; Bovenko VN
    Biull Eksp Biol Med; 1996 Sep; 122(9):359-60. PubMed ID: 8974501
    [No Abstract]   [Full Text] [Related]  

  • 9. The selection and evaluation of new chelating agents for the treatment of iron overload.
    Pitt CG; Gupta G; Estes WE; Rosenkrantz H; Metterville JJ; Crumbliss AL; Palmer RA; Nordquest KW; Hardy KA; Whitcomb DR; Byers BR; Arceneaux JE; Gaines CG; Sciortino CV
    J Pharmacol Exp Ther; 1979 Jan; 208(1):12-8. PubMed ID: 759605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ; Grady RW
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of desferal in treatment of sideroses of different origin. (Literature review)].
    Turbina NS
    Probl Gematol Pereliv Krovi; 1968 Jul; 13(7):47-52. PubMed ID: 4898933
    [No Abstract]   [Full Text] [Related]  

  • 12. [Iron chelate treatment of hereditary sideroblastic anemia complicated by hemochromatosis].
    Kremp L; Girot R; Alliot S; Najean Y; Douchain F; Hongre JF
    Arch Fr Pediatr; 1983; 40(6):475-7. PubMed ID: 6625846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines for diagnosis and treatment of secondary iron overload in patients with congenital anemia].
    Cario H; Grosse R; Janssen G; Jarisch A; Meerpohl J; Strauss G;
    Klin Padiatr; 2010 Nov; 222(6):399-406. PubMed ID: 20862634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron chelating therapy in thalassemia: current problems.
    Russo G
    Haematologica; 1990; 75 Suppl 5():84-8. PubMed ID: 2086385
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload.
    Schafer AI; Rabinowe S; Le Boff MS; Bridges K; Cheron RG; Dluhy R
    Arch Intern Med; 1985 Jul; 145(7):1217-21. PubMed ID: 3925909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chelation therapy for iron overload.
    Nutr Rev; 1980 May; 38(5):185-7. PubMed ID: 7207885
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of iron overload in the pediatric patient.
    Cohen A
    Hematol Oncol Clin North Am; 1987 Sep; 1(3):521-44. PubMed ID: 3329185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis of anemias associated with iron metabolism disorders].
    Apollonova LA
    Ter Arkh; 1970 Jul; 42(7):75-9. PubMed ID: 5477572
    [No Abstract]   [Full Text] [Related]  

  • 19. Ferrioxamine excretion in iron-loaded man.
    Pippard MJ; Callender ST; Finch CA
    Blood; 1982 Aug; 60(2):288-94. PubMed ID: 7093519
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitamin C and iron.
    Nienhuis AW
    N Engl J Med; 1981 Jan; 304(3):170-1. PubMed ID: 7442737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.